Clinical Trial Update: Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of fludarabine, rituximab, and alemtuzumab in patients with chronic lymphocytic leukemia or small lymphocytic lymphom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Lymphoma, Small Lymphocytic, Lymphocytic Leukemia, Chronic | Phase 2 | Status: COMPLETED